191 related articles for article (PubMed ID: 10690988)
1. Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources.
Ellis RJ; Gamst AC; Capparelli E; Spector SA; Hsia K; Wolfson T; Abramson I; Grant I; McCutchan JA
Neurology; 2000 Feb; 54(4):927-36. PubMed ID: 10690988
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
Spudich SS; Nilsson AC; Lollo ND; Liegler TJ; Petropoulos CJ; Deeks SG; Paxinos EE; Price RW
BMC Infect Dis; 2005 Nov; 5():98. PubMed ID: 16266436
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
[TBL] [Abstract][Full Text] [Related]
4. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.
Marra CM; Maxwell CL; Collier AC; Robertson KR; Imrie A
BMC Infect Dis; 2007 May; 7():37. PubMed ID: 17475004
[TBL] [Abstract][Full Text] [Related]
5. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.
García F; Niebla G; Romeu J; Vidal C; Plana M; Ortega M; Ruiz L; Gallart T; Clotet B; Miró JM; Pumarola T; Gatell JM
AIDS; 1999 Aug; 13(12):1491-6. PubMed ID: 10465072
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.
Cinque P; Bestetti A; Morelli P; Presi S
J Neurovirol; 2000 May; 6 Suppl 1():S95-S102. PubMed ID: 10871772
[TBL] [Abstract][Full Text] [Related]
8. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.
Canestri A; Lescure FX; Jaureguiberry S; Moulignier A; Amiel C; Marcelin AG; Peytavin G; Tubiana R; Pialoux G; Katlama C
Clin Infect Dis; 2010 Mar; 50(5):773-8. PubMed ID: 20100092
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid response to structured treatment interruption after virological failure.
Price RW; Paxinos EE; Grant RM; Drews B; Nilsson A; Hoh R; Hellmann NS; Petropoulos CJ; Deeks SG
AIDS; 2001 Jul; 15(10):1251-9. PubMed ID: 11426069
[TBL] [Abstract][Full Text] [Related]
10. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.
Strain MC; Letendre S; Pillai SK; Russell T; Ignacio CC; Günthard HF; Good B; Smith DM; Wolinsky SM; Furtado M; Marquie-Beck J; Durelle J; Grant I; Richman DD; Marcotte T; McCutchan JA; Ellis RJ; Wong JK
J Virol; 2005 Feb; 79(3):1772-88. PubMed ID: 15650202
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen.
Yilmaz A; Ståhle L; Hagberg L; Svennerholm B; Fuchs D; Gisslén M
Scand J Infect Dis; 2004; 36(11-12):823-8. PubMed ID: 15764168
[TBL] [Abstract][Full Text] [Related]
12. Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia.
Nightingale S; Geretti AM; Beloukas A; Fisher M; Winston A; Else L; Nelson M; Taylor S; Ustianowski A; Ainsworth J; Gilson R; Haddow L; Ong E; Watson V; Leen C; Minton J; Post F; Pirmohamed M; Solomon T; Khoo S
J Neurovirol; 2016 Dec; 22(6):852-860. PubMed ID: 27194435
[TBL] [Abstract][Full Text] [Related]
13. Distribution of Human Immunodeficiency Virus (HIV) Ribonucleic Acid in Cerebrospinal Fluid and Blood Is Linked to CD4/CD8 Ratio During Acute HIV.
Chan P; Patel P; Hellmuth J; Colby DJ; Kroon E; Sacdalan C; Pinyakorn S; Jagodzinski L; Krebs S; Ananworanich J; Valcour V; Spudich S;
J Infect Dis; 2018 Aug; 218(6):937-945. PubMed ID: 29741638
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma.
Haas DW; Clough LA; Johnson BW; Harris VL; Spearman P; Wilkinson GR; Fletcher CV; Fiscus S; Raffanti S; Donlon R; McKinsey J; Nicotera J; Schmidt D; Shoup RE; Kates RE; Lloyd RM; Larder B
AIDS Res Hum Retroviruses; 2000 Oct; 16(15):1491-502. PubMed ID: 11054262
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.
Foudraine NA; Hoetelmans RM; Lange JM; de Wolf F; van Benthem BH; Maas JJ; Keet IP; Portegies P
Lancet; 1998 May; 351(9115):1547-51. PubMed ID: 10326538
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.
Rawson T; Muir D; Mackie NE; Garvey LJ; Everitt A; Winston A
J Infect; 2012 Sep; 65(3):239-45. PubMed ID: 22522289
[TBL] [Abstract][Full Text] [Related]
18. HIV Type 1 replication in cerebrospinal fluid of patients with AIDS-related non-Hodgkin's lymphoma receiving chemotherapy and antiretroviral therapy.
Giancola ML; Uccella I; Alba L; Lorenzini P; Soldani F; Capobianchi M; Ruco L; Perno CF; Antinori A
AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1091-5. PubMed ID: 14709245
[TBL] [Abstract][Full Text] [Related]
19. Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers.
Dahl V; Peterson J; Spudich S; Lee E; Shacklett BL; Price RW; Palmer S
AIDS; 2013 Apr; 27(7):1145-9. PubMed ID: 23211774
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
Anderson AM; Muñoz-Moreno JA; McClernon DR; Ellis RJ; Cookson D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Franklin DR; Heaton RK; Grant I; Letendre SL;
J Infect Dis; 2017 Jan; 215(1):105-113. PubMed ID: 27789723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
